Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564927 | PMC |
| http://dx.doi.org/10.1165/rcmb.2022-0287ED | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Graphene quantum dot/Ag-based metal-organic framework nanocomposite-modified carbon paste electrode for simultaneous determination of diazepam, dopamine, clonazepam and adrenaline in real samples.
Anal Methods
August 2025
Department of Chemistry, Islamic Azad University, Yazd Branch, Yazd, Iran.
This research introduces a novel nanocomposite comprising graphene quantum dots (GQDs) and a silver-based metal-organic framework (Ag-MOF), referred to as GQD-Ag-MOF, which was utilized as a modifier in order to develop an electrochemical sensor for the quantification of diazepam. The as-prepared nanocomposite was characterized by Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction analysis (XRD), dynamic light scattering (DLS), field-emission scanning electron microscopy (FESEM), and transmission electron microscopy (TEM). The results of cyclic voltammetry (CV) experiments demonstrated that the GQD-Ag-MOF-modified carbon paste electrode (GQD-Ag-MOF/CPE) demonstrated excellent electrocatalytic activity for the oxidation of diazepam.
View Article and Find Full Text PDFComparison of the effects of esketamine/midazolam and remifentanil/midazolam on respiratory mechanics in mechanically ventilated patients with acute respiratory distress syndrome.
BMC Anesthesiol
July 2025
Department of Critical Care Medicine, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Background: Esketamine exerts analgesic effects and has pharmacological properties of bronchodilation and elevation of mean arterial pressure, making it an interesting analgesic agent for patients with ARDS. Therefore, we conducted a randomized controlled trial comparing the effects of esketamine/midazolam and remifentanil/midazolam on respiratory mechanics and oxygenation in mechanically ventilated patients with ARDS.
Methods: In this prospective, randomized, controlled study, patients with ARDS who were undergoing mechanical ventilation were randomly assigned to receive either remifentanil/midazolam (n = 25) or esketamine/midazolam (n = 25).
Cystamine reduces neurodegeneration and epileptogenesis following soman-induced status epilepticus in rats.
Exp Biol Med (Maywood)
June 2025
Neuroscience Department, U.S. Army Medical Research Institute of Chemical Defense (USAMRICD), Aberdeen, MD, United States.
Acute exposure to a seizure-inducing dose of an organophosphorus nerve agent inhibits acetylcholinesterase, leading to pharmacoresistance if benzodiazepine treatment is delayed. Following soman-induced status epilepticus (SE) in rats, prolonged seizure is associated with severe and widespread neurodegeneration. We evaluated the aminothiol cystamine, the oxidized form of cysteamine, for neuroprotective potential against soman-induced SE and associated neurodegeneration.
View Article and Find Full Text PDFIrinotecan-induced dysarthria and management.
J Oncol Pharm Pract
September 2025
Department of Pharmacy, Methodist University Hospital, Memphis, TN, USA.
BackgroundIrinotecan is chemotherapeutic agent often used in abdominal cancers such as colorectal and pancreatic cancers. While often associated with non-central nervous system (CNS) adverse effects, in rare cases it may present with paresthesias and dysarthrias. In one case, a patient received an irinotecan-containing regimen (fluorouracil, irinotecan, oxaliplatin) and experienced several neurotoxic effects, which was successfully managed.
View Article and Find Full Text PDFPsilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways.
Pharmacol Res Perspect
April 2025
Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Epilepsy, a chronic neurological disorder affecting around 65 million people globally, is characterized by recurrent, unprovoked epileptic seizures. Psilocin, the active metabolite of psilocybin, a well-known psychedelic compound, has recently gained attention for its potential antidepressant and anxiolytic properties. This study aims to investigate the anticonvulsant effects of psilocin.
View Article and Find Full Text PDF